{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-153071","form_type":"8-K","ticker":"ENTA","cik":"0001177648","company_name":"ENANTA PHARMACEUTICALS INC","filed_at":"2022-05-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.949105+00:00","generated_at":"2026-06-25T11:19:01.859450+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Enanta signs 10-year lease for ~73k sq ft HQ expansion in Watertown, MA; amends existing leases","bullets":["New lease with ARE-MA Region No. 75 for ~73,000 sq ft at Arsenal on the Charles; 10-year term starting June 2024.","Aggregate minimum lease payments under new lease: ~$76.5M; base rent ~$0.6M/month with 3% annual escalations.","Tenant improvement allowance of ~$15.0M; one-time extension option for additional 5 years at market rate.","Second Amendment shortens 500 Arsenal St lease to ~June 2024; aggregate remaining payments ~$6.5M.","First Amendment at 400 Talcott Ave adds ~20,000 sq ft office space; lease extended to June 2034; aggregate payments ~$19.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-153071","json":"https://secwatch.observer/filing/0001193125-22-153071.json","markdown":"https://secwatch.observer/filing/0001193125-22-153071.md","text":"https://secwatch.observer/filing/0001193125-22-153071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177648/000119312522153071/0001193125-22-153071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177648/000119312522153071/d349963d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T11:19:01.859450+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}